KAHANB.D.Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation1985; 40: 457–76.
2.
LAUPACISA., KEOWNP.A., ULANR.A., MCKENZIEN., STILLERC.R.Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J1982; 126: 1041–6.
3.
PTACHCINSKIR.J., BURCKARTG.J., VENKATARAMANANR.Cyclosporine. Drug Intell Clin Pharm1985; 19: 90–100.
4.
PTACHCINSKIR.J., BURCKARTG.J., VENKATARAMANANR.Cyclosporine concentration determination for monitoring and pharmacokinetic studies. J Clin Pharmacol1986; 26: 358–66.
5.
KENNEDYM.S., DEEGH.J., SIEGELM., CROWLEYJ.J., STORBR., THOMAS ed. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation1983; 35: 211–5.
6.
WHITINGP.H., SIMPSONS.G., THOMSONA.W.Nephrotoxicity of cyclosporine in combination with aminoglycoside and cephalosporin antibiotics. In: KahanB.D., ed. Cyclosporine. Vol I. Biological activity and clinical applications.London: Grune and Stratton, 1983: 486–9.
7.
MORGENSTERNG.R., POWLESR., ROBINSONB., MCELWAINT.J.Cyclosporin interaction with ketoconazole and melphalan. Lancet1982; 2: 1342.
8.
THOMSONJ.F., CHALMERSD.H.K., HUNNISETTA.G.W., WOODR.F.M., MORRISP.J.Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine. Transplantation1983; 36: 204–6.
9.
MAURERG.Metabolism of cyclosporine. Transplant Proc1985; 17: 19–26.
10.
FREENANDJ, LAUPACISA., KEOWNPA, STILLERCR, CARRUTHERSSG.Evaluation of cyclosporin-phenytoin interactions with observations on cyclosporin metabolites. Br J Clin Pharmacol1984; 18: 887–93.
11.
PTACHCINSKIR.J., CARPENTERB.J., BURCKARTG.J., VENKATARAMANANR., ROSENTHALJ.T.Effect of erythromycin on cyclosporine levels. N Engl J Med1985; 313: 1416–7.